Kathleen C. Day
- Molecular Biology top 10%
- Oncology top 5%
- Biomedical Engineering top 10%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- Mark L. DayAbdo J. NajySheng-Wen HuangShai AshkenaziMatthew O’DonnellAshish AgarwalNicholas A. KotovMark A. Rubin
- Topics
- Bladder and Urothelial Cancer Treatments (7 papers)Peptidase Inhibition and Analysis (6 papers)HER2/EGFR in Cancer Research (6 papers)
- Partner nations
- United StatesGermanyEgypt
In The Last Decade
Kathleen C. Day
36 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 106
- Molecular Biology 873
- Oncology 506
- Biomedical Engineering 464
- Pulmonary and Respiratory Medicine 289
- Cancer Research 254
Countries citing papers authored by Kathleen C. Day
This map shows the geographic impact of Kathleen C. Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen C. Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen C. Day more than expected).
Fields of papers citing papers by Kathleen C. Day
This network shows the impact of papers produced by Kathleen C. Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen C. Day. The network helps show where Kathleen C. Day may publish in the future.
Co-authorship network of co-authors of Kathleen C. Day
This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen C. Day. A scholar is included among the top collaborators of Kathleen C. Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen C. Day. Kathleen C. Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 24 | |
| 4 | 17 | |
| 5 | 31 | |
| 6 | 145 | |
| 7 | 24 | |
| 8 | 11 | |
| 9 | 73 | |
| 10 | 154 | |
| 11 | 77 | |
| 12 | 0 | |
| 13 | 1 | |
| 14 | 148 | |
| 15 | 26 | |
| 16 | 88 | |
| 17 | 100 | |
| 18 | 101 | |
| 19 | 54 | |
| 20 | 6 |
About Kathleen C. Day
Kathleen C. Day is a scholar working on Oncology, Immunology and Allergy and Biotechnology, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Peptidase Inhibition and Analysis (6 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Immunology and Allergy (202 citations), Oncology (506 citations) and Cancer Research (254 citations). Kathleen C. Day has collaborated with scholars based in United States, Germany and Egypt. Frequent co-authors include Mark L. Day, Abdo J. Najy, Sheng-Wen Huang, Shai Ashkenazi, Matthew O’Donnell, Ashish Agarwal, Nicholas A. Kotov, Mark A. Rubin, Xin Zhao and Michael G. Rashid. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.